• Consensus Rating: N/A
  • Consensus Price Target: €31.20
  • Forecasted Upside: 110.67 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€14.81
▲ +0.01 (0.07%)

This chart shows the closing price for MOR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MorphoSys Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MOR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MOR

Analyst Price Target is €31.20
▲ +110.67% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for MorphoSys in the last 3 months. The average price target is €31.20, with a high forecast of €65.00 and a low forecast of €13.00. The average price target represents a 110.67% upside from the last price of €14.81.

This chart shows the closing price for MOR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in MorphoSys. This rating has held steady since May 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/6/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/4/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/3/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/3/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/28/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/25/2022Deutsche Bank AktiengesellschaftSet Target€13.00
11/21/2022JPMorgan Chase & Co.Set Target€18.00
11/14/2022JPMorgan Chase & Co.Set Target€32.50
10/31/2022JPMorgan Chase & Co.Set Target€32.50
10/24/2022Deutsche Bank AktiengesellschaftSet Target€18.00
10/24/2022JPMorgan Chase & Co.Set Target€32.50
10/17/2022JPMorgan Chase & Co.Set Target€32.50
9/28/2022JPMorgan Chase & Co.Set Target€32.50
8/10/2022JPMorgan Chase & Co.Set Target€32.50
8/4/2022The Goldman Sachs GroupSet Target€24.00
8/4/2022JPMorgan Chase & Co.Set Target€34.00
8/4/2022Berenberg BankSet Target€65.00
7/27/2022Deutsche Bank AktiengesellschaftSet Target€30.00
7/26/2022JPMorgan Chase & Co.Set Target€34.00
7/26/2022Berenberg BankSet Target€65.00
6/15/2022JPMorgan Chase & Co.Set Target€34.00
6/10/2022The Goldman Sachs GroupSet Target€24.00
5/27/2022Berenberg BankSet Target€65.00
5/17/2022JPMorgan Chase & Co.Set Target€34.00
5/11/2022JPMorgan Chase & Co.Set Target€34.00
5/5/2022Berenberg BankSet Target€65.00
5/4/2022Deutsche Bank AktiengesellschaftSet Target€30.00
3/24/2022Berenberg BankSet Target€65.00
3/22/2022Deutsche Bank AktiengesellschaftSet Target€30.00
3/17/2022JPMorgan Chase & Co.Set Target€40.00
3/17/2022BarclaysSet Target€36.00
3/11/2022Deutsche Bank AktiengesellschaftSet Target€46.00
2/1/2022Berenberg BankSet Target€124.00
1/31/2022BarclaysSet Target€36.00
1/17/2022JPMorgan Chase & Co.Set Target€40.00
1/10/2022Deutsche Bank AktiengesellschaftSet Target€46.00
1/10/2022BarclaysSet Target€47.00
1/10/2022JPMorgan Chase & Co.Set Target€40.00
1/5/2022Berenberg BankSet Target€124.00
1/4/2022JPMorgan Chase & Co.Lower Target€54.00 ➝ €40.00
11/15/2021Deutsche Bank AktiengesellschaftSet Target€46.00
11/12/2021Morgan StanleySet Target€76.00
11/11/2021Berenberg BankSet Target€124.00
11/11/2021BarclaysSet Target€47.00
11/11/2021The Goldman Sachs GroupSet Target€42.00
11/11/2021JPMorgan Chase & Co.Set Target€54.00
11/3/2021BarclaysSet Target€47.00
11/1/2021JPMorgan Chase & Co.Set Target€54.00
10/29/2021The Goldman Sachs GroupSet Target€42.00
10/21/2021Berenberg BankSet Target€124.00
10/6/2021JPMorgan Chase & Co.Set Target€54.00
9/27/2021Deutsche Bank AktiengesellschaftSet Target€46.00
9/17/2021Morgan StanleySet Target€75.00
9/13/2021The Goldman Sachs GroupSet Target€42.00
9/2/2021BarclaysSet Target€47.00
8/6/2021Deutsche Bank AktiengesellschaftSet Target€46.00
8/4/2021JPMorgan Chase & Co.Set Target€54.00
7/29/2021Berenberg BankSet Target€124.00
7/29/2021JPMorgan Chase & Co.Set Target€80.00
7/19/2021BarclaysSet Target€90.00
7/9/2021Morgan StanleySet Target€86.00
7/5/2021Stifel NicolausSet Target€97.00
6/16/2021Berenberg BankSet TargetBuy€140.00
6/14/2021JPMorgan Chase & Co.Set TargetNeutral€80.00
6/8/2021JPMorgan Chase & Co.Set TargetBuy€105.00
6/3/2021BarclaysSet TargetNeutral€90.00
6/3/2021Deutsche Bank AktiengesellschaftSet TargetBuy€116.00
6/2/2021JPMorgan Chase & Co.Set TargetBuy€105.00
5/24/2021Morgan StanleySet TargetBuy€90.00
5/21/2021JPMorgan Chase & Co.Set TargetBuy€105.00
5/11/2021The Goldman Sachs GroupSet TargetNeutral€75.00
5/11/2021Deutsche Bank AktiengesellschaftSet TargetBuy€116.00
5/6/2021Berenberg BankSet TargetBuy€140.00
5/6/2021Morgan StanleySet TargetNeutral€91.00
5/5/2021The Goldman Sachs GroupSet TargetNeutral€88.00
5/5/2021Deutsche Bank AktiengesellschaftSet TargetBuy€116.00
5/4/2021JPMorgan Chase & Co.Set TargetBuy€110.00
4/19/2021BarclaysSet TargetNeutral€90.00
4/8/2021Deutsche Bank AktiengesellschaftSet TargetBuy€116.00
3/25/2021JPMorgan Chase & Co.Set TargetBuy€110.00
3/22/2021The Goldman Sachs GroupSet TargetNeutral€88.00
3/17/2021Independent ResearchSet TargetBuy€95.00
3/17/2021Berenberg BankSet TargetBuy€140.00
3/16/2021Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
3/16/2021JPMorgan Chase & Co.Set TargetBuy€130.00
3/16/2021The Goldman Sachs GroupSet TargetNeutral€110.00
3/16/2021Royal Bank of CanadaSet TargetNeutral€130.00
3/3/2021Independent ResearchSet TargetBuy€120.00
3/3/2021Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
3/2/2021The Goldman Sachs GroupSet TargetNeutral€110.00
3/2/2021BarclaysSet TargetNeutral€90.00
2/10/2021BarclaysSet TargetNeutral€90.00
2/10/2021Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
2/9/2021The Goldman Sachs GroupSet TargetNeutral€110.00
2/9/2021JPMorgan Chase & Co.Set TargetBuy€130.00
1/22/2021BarclaysSet TargetNeutral€90.00
1/18/2021JPMorgan Chase & Co.Set TargetBuy€130.00
1/8/2021Morgan StanleySet TargetNeutral€105.00
1/4/2021JPMorgan Chase & Co.Set TargetBuy€130.00
12/14/2020Berenberg BankSet TargetBuy€140.00
12/3/2020JPMorgan Chase & Co.Set TargetBuy€120.00
11/27/2020Independent ResearchSet TargetBuy€120.00
11/25/2020Morgan StanleySet TargetNeutral€105.00
11/18/2020The Goldman Sachs GroupSet TargetNeutral€110.00
11/13/2020Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
11/13/2020Berenberg BankSet TargetBuy€140.00
11/13/2020BarclaysSet TargetNeutral€90.00
11/12/2020Royal Bank of CanadaSet TargetNeutral€130.00
10/28/2020The Goldman Sachs GroupSet TargetNeutral€110.00
10/14/2020The Goldman Sachs GroupSet TargetNeutral€110.00
10/5/2020Berenberg BankSet TargetBuy€140.00
10/5/2020The Goldman Sachs GroupSet TargetNeutral€110.00
10/2/2020BarclaysSet TargetNeutral€110.00
9/30/2020JPMorgan Chase & Co.Set TargetBuy€130.00
9/29/2020The Goldman Sachs GroupSet TargetNeutral€110.00
9/23/2020The Goldman Sachs GroupSet TargetNeutral€110.00
8/25/2020Independent ResearchSet TargetNeutral€117.00
8/17/2020BarclaysSet TargetNeutral€105.00
8/17/2020The Goldman Sachs GroupSet TargetNeutral€110.00
8/10/2020Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
8/3/2020Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
8/3/2020The Goldman Sachs GroupSet TargetNeutral€114.00
8/3/2020Royal Bank of CanadaSet TargetNeutral€130.00
8/3/2020JPMorgan Chase & Co.Set TargetBuy€130.00
7/27/2020Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
7/17/2020The Goldman Sachs GroupSet TargetNeutral€114.00
6/10/2020The Goldman Sachs GroupSet TargetNeutral€114.00
6/2/2020The Goldman Sachs GroupSet TargetNeutral€114.00
5/22/2020JPMorgan Chase & Co.Set TargetBuy€130.00
5/21/2020Royal Bank of CanadaSet TargetBuy€113.00
5/14/2020JPMorgan Chase & Co.Set TargetBuy€150.00
5/14/2020Independent ResearchSet TargetBuy€138.00
5/13/2020BarclaysSet TargetNeutral€105.00
5/12/2020HSBCSet TargetNeutral€114.00
5/8/2020The Goldman Sachs GroupSet TargetNeutral€114.00
5/7/2020JPMorgan Chase & Co.Set TargetBuy€150.00
5/7/2020Royal Bank of CanadaSet TargetBuy€113.00
4/15/2020The Goldman Sachs GroupSet TargetNeutral€114.00
4/7/2020The Goldman Sachs GroupSet TargetNeutral€114.00
3/24/2020BarclaysSet TargetNeutral€110.00
3/23/2020Berenberg BankSet TargetBuy€150.00
3/23/2020Independent ResearchSet TargetBuy€119.00
3/19/2020Royal Bank of CanadaSet TargetBuy€130.00
3/19/2020JPMorgan Chase & Co.Reiterated RatingBuy
3/3/2020Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
2/5/2020Berenberg BankSet TargetBuy€150.00
2/3/2020BarclaysSet TargetNeutral€110.00
1/23/2020Berenberg BankSet TargetBuy€150.00
1/22/2020Independent ResearchSet TargetNeutral€130.00
1/22/2020The Goldman Sachs GroupReiterated RatingNeutral
1/20/2020JPMorgan Chase & Co.Set TargetBuy€150.00
1/15/2020Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
1/13/2020Berenberg BankSet TargetBuy€145.00
1/13/2020The Goldman Sachs GroupSet TargetNeutral€114.00
1/13/2020JPMorgan Chase & Co.Set TargetBuy€150.00
1/6/2020JPMorgan Chase & Co.Set TargetBuy€150.00
1/2/2020The Goldman Sachs GroupSet TargetNeutral€114.00
12/11/2019JPMorgan Chase & Co.Set TargetBuy€130.00
12/10/2019Royal Bank of CanadaSet TargetBuy€130.00
12/10/2019Berenberg BankSet TargetBuy€145.00
12/6/2019Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
12/4/2019Berenberg BankSet TargetBuy€145.00
11/19/2019The Goldman Sachs GroupSet TargetNeutral€114.00
11/19/2019Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
11/19/2019Berenberg BankSet TargetBuy€145.00
11/19/2019Royal Bank of CanadaSet TargetBuy€130.00
11/18/2019JPMorgan Chase & Co.Set TargetBuy€130.00
11/11/2019Berenberg BankSet TargetBuy€145.00
11/7/2019Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
11/7/2019Royal Bank of CanadaSet TargetBuy€130.00
11/1/2019Independent ResearchSet TargetNeutral€110.00
11/1/2019Deutsche Bank AktiengesellschaftSet TargetBuy€129.00
10/30/2019JPMorgan Chase & Co.Set TargetBuy€130.00
10/29/2019Berenberg BankSet TargetBuy€150.00
10/29/2019Royal Bank of CanadaSet TargetBuy€130.00
10/29/2019The Goldman Sachs GroupSet TargetNeutral€114.00
9/26/2019The Goldman Sachs GroupSet TargetNeutral€114.00
9/24/2019Independent ResearchSet TargetNeutral€117.00
9/11/2019JPMorgan Chase & Co.Set TargetBuy€130.00
9/9/2019Berenberg BankSet TargetBuy€150.00
8/16/2019HSBCSet TargetSell€81.00
8/13/2019Independent ResearchSet TargetNeutral€116.00
8/9/2019Royal Bank of CanadaSet TargetBuy€130.00
8/8/2019Deutsche Bank AktiengesellschaftSet TargetBuy€133.00
8/7/2019The Goldman Sachs GroupSet TargetNeutral€114.00
8/7/2019JPMorgan Chase & Co.Set TargetBuy€120.00
8/5/2019Berenberg BankSet TargetBuy€150.00
7/18/2019Deutsche Bank AktiengesellschaftSet TargetBuy€133.00
7/16/2019JPMorgan Chase & Co.Set TargetBuy€120.00
7/4/2019Independent ResearchSet TargetNeutral€96.00
6/26/2019Independent ResearchSet TargetNeutral€96.00
6/24/2019Royal Bank of CanadaSet TargetSell€65.00
6/24/2019JPMorgan Chase & Co.Set TargetBuy€120.00
6/24/2019The Goldman Sachs GroupSet TargetNeutral€114.00
6/17/2019The Goldman Sachs GroupSet TargetNeutral€114.00
6/11/2019Berenberg BankSet TargetBuy€108.00
6/11/2019The Goldman Sachs GroupSet TargetNeutral€114.00
5/29/2019JPMorgan Chase & Co.Set TargetBuy€120.00
5/23/2019The Goldman Sachs GroupSet TargetNeutral€114.00
5/21/2019Berenberg BankSet TargetBuy€108.00
5/17/2019Royal Bank of CanadaSet TargetSell€65.00
5/17/2019JPMorgan Chase & Co.Set TargetBuy€120.00
5/17/2019The Goldman Sachs GroupSet TargetNeutral€114.00
5/15/2019Berenberg BankSet TargetBuy€108.00
5/9/2019The Goldman Sachs GroupSet TargetNeutral€114.00
5/9/2019Deutsche Bank AktiengesellschaftSet TargetBuy€125.00
5/9/2019Independent ResearchSet TargetNeutral€96.00
5/8/2019JPMorgan Chase & Co.Set TargetBuy€120.00
4/26/2019Deutsche Bank AktiengesellschaftSet TargetBuy€125.00
4/16/2019JPMorgan Chase & Co.Set TargetBuy€120.00
4/4/2019JPMorgan Chase & Co.Set TargetBuy€120.00
4/2/2019Berenberg BankSet TargetBuy€108.00
3/25/2019The Goldman Sachs GroupSet TargetNeutral€114.00
3/18/2019The Goldman Sachs GroupSet TargetNeutral€114.00
3/15/2019Deutsche Bank AktiengesellschaftSet TargetBuy€125.00
3/14/2019Independent ResearchSet TargetNeutral€96.00
3/14/2019Royal Bank of CanadaSet TargetSell€65.00
3/11/2019JPMorgan Chase & Co.Reiterated RatingBuy€135.00
3/11/2019The Goldman Sachs GroupSet TargetNeutral€114.00
3/6/2019Deutsche Bank AktiengesellschaftSet TargetBuy€125.00
2/28/2019Berenberg BankSet TargetNeutral€108.00
2/21/2019Berenberg BankSet TargetNeutral€108.00
2/15/2019Berenberg BankSet TargetNeutral€108.00
2/4/2019Royal Bank of CanadaSet TargetSell€65.00
1/29/2019The Goldman Sachs GroupSet TargetNeutral€114.00
1/29/2019Deutsche Bank AktiengesellschaftSet TargetBuy€125.00
1/28/2019JPMorgan Chase & Co.Set TargetBuy€135.00
1/28/2019Royal Bank of CanadaSet TargetSell€65.00
1/23/2019Deutsche Bank AktiengesellschaftReiterated RatingBuy€125.00
1/18/2019The Goldman Sachs GroupSet TargetNeutral€114.00
1/14/2019JPMorgan Chase & Co.Set TargetBuy€135.00
1/2/2019JPMorgan Chase & Co.Set TargetBuy€135.00
12/17/2018The Goldman Sachs GroupSet TargetNeutral€114.00
12/12/2018JPMorgan Chase & Co.Reiterated RatingBuy
12/10/2018Deutsche Bank AktiengesellschaftSet TargetBuy€130.00
12/6/2018JPMorgan Chase & Co.Set TargetBuy€120.00
12/3/2018Royal Bank of CanadaSet TargetSell€65.00
11/28/2018Independent ResearchSet TargetNeutral€104.00
11/26/2018Royal Bank of CanadaSet TargetSell€65.00
11/19/2018Oddo BhfSet TargetBuy€116.00
11/16/2018CommerzbankSet TargetNeutral€107.00
11/13/2018JPMorgan Chase & Co.Set TargetBuy€120.00
11/8/2018Oddo BhfSet TargetBuy€116.00
11/7/2018JPMorgan Chase & Co.Set TargetBuy€110.00
11/6/2018The Goldman Sachs GroupSet TargetNeutral€86.00
11/6/2018CommerzbankSet TargetNeutral€107.00
11/2/2018Oddo BhfSet TargetBuy€116.00
11/2/2018Royal Bank of CanadaSet TargetSell€65.00
11/1/2018JPMorgan Chase & Co.Reiterated RatingBuy€110.00
10/15/2018Royal Bank of CanadaSet TargetSell€65.00
10/11/2018Oddo BhfSet TargetBuy€110.00
10/1/2018JPMorgan Chase & Co.Set TargetBuy€110.00
10/1/2018Royal Bank of CanadaSet TargetSell€65.00
9/27/2018Independent ResearchSet TargetNeutral€105.00
9/26/2018The Goldman Sachs GroupSet TargetNeutral€86.00
9/7/2018Berenberg BankSet TargetNeutral€108.00
8/22/2018CommerzbankSet TargetNeutral€107.00
8/14/2018HSBCSet TargetSell€56.00
8/7/2018Independent ResearchSet TargetNeutral€120.00
8/6/2018Deutsche Bank AktiengesellschaftSet TargetNeutral€120.00
8/3/2018Oddo BhfSet TargetNeutral€110.00
8/2/2018Berenberg BankSet TargetBuy€103.00
8/2/2018JPMorgan Chase & Co.Set TargetBuy€100.00
7/31/2018CommerzbankSet TargetBuy€98.00
7/30/2018Deutsche Bank AktiengesellschaftSet TargetNeutral€120.00
7/27/2018Oddo BhfSet TargetBuy€110.00
7/20/2018Independent ResearchSet TargetNeutral€120.00
7/19/2018CommerzbankSet TargetBuy€98.00
7/19/2018Royal Bank of CanadaSet TargetSell€62.00
7/19/2018JPMorgan Chase & Co.Set TargetBuy€100.00
7/19/2018Oddo BhfSet TargetBuy€110.00
7/6/2018Independent ResearchSet TargetNeutral€110.00
6/18/2018Oddo BhfSet TargetBuy€106.00
6/13/2018Royal Bank of CanadaSet TargetSell€62.00
5/31/2018Royal Bank of CanadaSet TargetSell€62.00
5/24/2018The Goldman Sachs GroupSet TargetNeutral€86.00
5/23/2018Berenberg BankSet TargetBuy€103.00
5/17/2018JPMorgan Chase & Co.Set TargetBuy€100.00
5/15/2018Berenberg BankSet TargetBuy€103.00
5/8/2018Independent ResearchSet TargetBuy€103.00
5/4/2018Oddo BhfSet TargetBuy€93.00
5/3/2018The Goldman Sachs GroupSet TargetNeutral€86.00
5/2/2018Royal Bank of CanadaSet TargetSell€58.00
5/2/2018CommerzbankSet TargetBuy€98.00
5/1/2018Deutsche Bank AktiengesellschaftSet TargetBuy€95.00
4/18/2018CommerzbankSet TargetBuy€98.00
4/9/2018Bryan, Garnier & CoSet TargetBuy€91.00
3/19/2018CommerzbankSet TargetBuy€98.00
3/14/2018Oddo BhfSet TargetBuy€93.00
3/14/2018Bryan, Garnier & CoSet TargetBuy€91.20
3/14/2018The Goldman Sachs GroupSet TargetNeutral€86.00
3/13/2018Independent ResearchSet TargetBuy€97.00
3/13/2018Berenberg BankSet TargetBuy€85.00
3/13/2018Royal Bank of CanadaSet TargetSell€57.00
3/13/2018JPMorgan Chase & Co.Reiterated RatingBuy€100.00
3/12/2018CommerzbankSet TargetBuy€98.00
3/12/2018Deutsche Bank AktiengesellschaftSet TargetBuy€94.00
3/8/2018The Goldman Sachs GroupSet TargetNeutral€86.00
2/20/2018Oddo BhfSet TargetBuy€90.00
2/14/2018Royal Bank of CanadaSet TargetSell€57.00
1/19/2018HSBCSet TargetSell€64.00
1/15/2018JPMorgan Chase & Co.Reiterated RatingBuy
1/4/2018JPMorgan Chase & Co.Set TargetBuy€97.00
12/29/2017JPMorgan Chase & Co.Set TargetBuy€97.00
12/12/2017JPMorgan Chase & Co.Set TargetBuy€86.00
12/7/2017Berenberg BankSet TargetBuy€85.00
12/1/2017Independent ResearchSet TargetBuy€93.00
(Data available from 11/28/2017 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/2/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/1/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/1/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/31/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/30/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/29/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/29/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/28/2022

Current Sentiment

  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
MorphoSys logo
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The company also develops Pelabresib, a small molecule that is in Phase II clinical trial to treat myelofibrosis; Felzartamab, an antibody directed against CD38, which is in Phase I/II clinical trials for the treatment of anti-PLA2R-positive membranous nephropathy, an autoimmune disease; and CPI-0209, a small molecule that is in Phase I/II designed to promote anti-tumor activity by inhibiting EZH2. In addition, it develops Gantenerumab, an antibody for the treatment of Alzheimer's diseases through its pharmaceutical partners; Otilimab, an antibody for rheumatoid arthritis; Tremfya, an antibody to treat psoriasis, psoriatic arthritis, and palmoplantar pustulosis; and MOR210/TJ210, an antibody to treat immuno-oncology and autoimmune diseases. MorphoSys AG has a regional licensing agreement with I-Mab Biopharma to develop and commercialize felzartamab in China, Taiwan, Hong Kong, and Macau; a strategic alliance with the LEO Pharma; a joint collaboration and license agreement with Incyte Corporation to develop and commercialize MorphoSys investigational compound tafasitamab; and a clinical collaboration with Incyte Corporation and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was founded in 1992 and is headquartered in Planegg, Germany.
Read More

Today's Range

Now: €14.81
Low: €14.20
High: €14.81

50 Day Range

MA: €19.14
Low: €14.40
High: €23.35

52 Week Range

Now: €14.81
Low: €13.90
High: €38.11

Volume

340,631 shs

Average Volume

153,687 shs

Market Capitalization

$505.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MorphoSys?

The following Wall Street sell-side analysts have issued reports on MorphoSys in the last year: Barclays PLC, Berenberg Bank, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., and The Goldman Sachs Group, Inc..
View the latest analyst ratings for MOR.

What is the current price target for MorphoSys?

5 Wall Street analysts have set twelve-month price targets for MorphoSys in the last year. Their average twelve-month price target is €31.20, suggesting a possible upside of 110.7%. Berenberg Bank has the highest price target set, predicting MOR will reach €65.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of €13.00 for MorphoSys in the next year.
View the latest price targets for MOR.

What is the current consensus analyst rating for MorphoSys?

MorphoSys currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MOR.

What other companies compete with MorphoSys?

How do I contact MorphoSys' investor relations team?

MorphoSys' physical mailing address is Semmelweisstr. 7, PLANEGG, 82152, Germany. The company's listed phone number is +49-89-899270. The official website for MorphoSys is www.morphosys.de. Learn More about contacing MorphoSys investor relations.